Co-Diagnostics, Inc. Operating Lease, Payments
Co-Diagnostics, Inc. (CODX) reported Operating Lease, Payments of $264.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Co-Diagnostics, Inc. operating lease, payments for the quarter ending 2026-06-30 was $1.85K, a 99.29% decline year-over-year.
- Co-Diagnostics, Inc. operating lease, payments for the quarter ending 2026-03-31 was $263.04K, a 2.10% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, payments for the quarter ending 2025-12-31 was $264.88K, a 0.17% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, payments for the quarter ending 2025-09-30 was $262.62K, a 0.83% decline year-over-year.
- Co-Diagnostics, Inc. operating lease, payments for fiscal 2025 was $1.05M, a 0.44% decline from fiscal 2024.
- Co-Diagnostics, Inc. operating lease, payments for fiscal 2024 was $1.05M, a 10.09% increase from fiscal 2023.
- Co-Diagnostics, Inc. operating lease, payments for fiscal 2023 was $954.01K, a 36.13% increase from fiscal 2022.
- Co-Diagnostics, Inc. operating lease, payments for fiscal 2022 was $700.82K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $264.89K 10-Q · filed 2026-08-13 | $529.77K derived: sum of 3 quarters · filed 2026-08-13 | $792.39K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $263.04K 10-Q · filed 2026-05-14 | $527.91K derived: sum of 2 quarters · filed 2026-05-14 | $790.54K derived: sum of 3 quarters · filed 2026-05-14 | $1.05M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $264.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $527.50K derived: sum of 2 quarters · filed 2026-03-31 | $788.07K derived: sum of 3 quarters · filed 2026-03-31 | $1.05M 10-K · filed 2026-03-31 |
| 2025-09-30 | $262.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $523.19K derived: sum of 2 quarters · filed 2025-11-13 | $780.81K 10-Q · filed 2025-11-13 | $1.05M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $260.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $518.19K 10-Q · filed 2025-08-14 | $782.62K derived: sum of 3 quarters · filed 2025-08-14 | $1.05M derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $257.63K 10-Q · filed 2025-05-08 | $522.05K derived: sum of 2 quarters · filed 2025-05-08 | $786.89K derived: sum of 3 quarters · filed 2025-05-08 | $1.05M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $264.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $529.26K derived: sum of 2 quarters · filed 2025-03-27 | $788.07K derived: sum of 3 quarters · filed 2025-03-27 | $1.05M 10-K · filed 2025-03-27 |
| 2024-09-30 | $264.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $523.64K derived: sum of 2 quarters · filed 2024-11-07 | $785.85K 10-Q · filed 2024-11-07 | $1.06M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $258.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $521.02K 10-Q · filed 2024-08-08 | $794.45K derived: sum of 3 quarters · filed 2024-08-08 | $1.19M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $262.21K 10-Q · filed 2024-05-09 | $535.64K derived: sum of 2 quarters · filed 2024-05-09 | $934.80K derived: sum of 3 quarters · filed 2024-05-09 | $1.03M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $273.43K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $672.59K derived: sum of 2 quarters · filed 2024-03-14 | $765.18K derived: sum of 3 quarters · filed 2024-03-14 | $954.01K 10-K · filed 2024-03-14 |
| 2023-09-30 | $399.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $491.75K derived: sum of 2 quarters · filed 2023-11-09 | $680.58K 10-Q · filed 2023-11-09 | $867.39K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $92.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $281.42K 10-Q · filed 2023-08-10 | $468.23K derived: sum of 3 quarters · filed 2023-08-10 | $660.89K derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $188.84K 10-Q · filed 2023-05-11 | $375.65K derived: sum of 2 quarters · filed 2023-05-11 | $568.31K derived: sum of 3 quarters · filed 2023-05-11 | $735.75K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $186.81K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $379.47K derived: sum of 2 quarters · filed 2023-03-16 | $546.92K derived: sum of 3 quarters · filed 2023-03-16 | $700.82K 10-K · filed 2023-03-16 |
| 2022-09-30 | $192.66K 10-Q · filed 2022-11-10 | $360.10K derived: sum of 2 quarters · filed 2022-11-10 | $514.01K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $167.44K 10-Q · filed 2022-08-11 | $321.35K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $154.88K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |